Skip to main content
. 2022 Apr 13;15(4):e248335. doi: 10.1136/bcr-2021-248335

Figure 1.

Figure 1

Baseline audiogram prior to initiation of teprotumumab demonstrates mild hearing loss at 4000–8000 Hz, otherwise normal hearing threshold at 250–3000 Hz bilaterally. The right ear is slightly worse than the left ear by 10 dB at 250–1000 Hz.